Vanguard Capital Management
AEON icon

Vanguard Capital Management’s AEON Biopharma AEON Stock Holding History

Vanguard Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.1K Hold
90,529
– – ﹤0.01% 3914
2026
Q1 		$89.2K Buy
+90,529
New +$101K ﹤0.01% 3873

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management's AEON Position: Q2 2026 in Review

Vanguard Capital Management held its AEON Biopharma (AEON) position steady in Q2 2026 at 90,529 shares worth $65.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3914.

Vanguard Capital Management first reported a position in AEON in Q1 2026 and has held it in 2 quarters since. The position peaked at $89.2K in Q1 2026. 23 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Vanguard Capital Management held 90,529 shares of AEON Biopharma worth $65.1K as of Q2 2026.
  • Vanguard Capital Management left its AEON Biopharma share count unchanged in Q2 2026.
  • AEON Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3914 holding.
  • Vanguard Capital Management first reported a position in AEON Biopharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's AEON Biopharma position peaked at $89.2K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.